Zevra Therapeutics
ZVRA
ZVRA
72 hedge funds and large institutions have $32.6M invested in Zevra Therapeutics in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 30 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
less call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
43% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 23
63% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 30
Holders
72
Holding in Top 10
2
Calls
$5.47M
Puts
$5.93M
Top Buyers
| 1 | +$2.6M | |
| 2 | +$1.85M | |
| 3 | +$644K | |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$584K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$307K |
Top Sellers
| 1 | -$6.25M | |
| 2 | -$2M | |
| 3 | -$995K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$911K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$608K |